GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR


Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.

Globally, more than three million childhood deaths result from infectious diseases,

Read More